You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

gsk2248761

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Infection, Human Immunodeficiency Virus, HIV Trial in Fargo (YASMIN, GSK2248761, Placebo)

Terminated
  • Infection, Human Immunodeficiency Virus
  • HIV Infections
  • Fargo, North Dakota
    GSK Investigational Site
Feb 18, 2019

Infection, Human Immunodeficiency Virus Trial in Buenos Aires (GSK2248761, Lopinavir/ritonavir, HAART)

Completed
Has Results
  • Infection, Human Immunodeficiency Virus
  • GSK2248761
  • +3 more
  • Buenos Aires, Argentina
    GSK Investigational Site
May 4, 2018

Infection, Human Immunodeficiency Virus Trial in Buffalo (Raltegravir, GSK2248761, GSK2248761 + Raltegravir)

Completed
  • Infection, Human Immunodeficiency Virus
  • Buffalo, New York
    GSK Investigational Site
Sep 8, 2017

Infection, Human Immunodeficiency Virus I Trial in Buffalo (GSK1349572, GSK2248761)

Withdrawn
  • Infection, Human Immunodeficiency Virus I
  • Buffalo, New York
    GSK Investigational Site
Dec 22, 2014

Infection, Human Immunodeficiency Virus Trial in Austin (GSK2248761, Simvastatin, Atorvastatin)

Completed
  • Infection, Human Immunodeficiency Virus
  • GSK2248761
  • +3 more
  • Austin, Texas
    GSK Investigational Site
Nov 4, 2010

Healthy Subjects, Infection, Human Immunodeficiency Virus Trial in Baltimore (darunavir/ritonavir, lopinavir/ritonavir,

Completed
  • Healthy Subjects
  • Infection, Human Immunodeficiency Virus
  • Baltimore, Maryland
    GSK Investigational Site
Nov 2, 2010